Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NASDAQ:PHMMF
- CUSIP: N/A
- Web: N/A
- 50 Day Moving Avg: $4.42
- 200 Day Moving Avg: $4.09
- 52 Week Range: $2.40 - $4.80
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: $222.8 million
- Price / Sales: N/A
- Book Value: $0.28 per share
- Price / Book: 14.46
- Average Volume: 6,837 shs.
Frequently Asked Questions for Pharma Mar (NASDAQ:PHMMF)
What is Pharma Mar's stock symbol?
Pharma Mar trades on the NASDAQ under the ticker symbol "PHMMF."
Who are some of Pharma Mar's key competitors?
Some companies that are related to Pharma Mar include Dometic Group Ab (DTCGF), Potlatch Corporation (PCH), Towne Bank (TOWN), Renasant Corporation (RNST), Hawaiian Holdings (HA), Atlantica Yield PLC (ABY), Allegiant Travel Company (ALGT), Horizon Pharma PLC (HZNP), Coca-Cola Bottling Co. Consolidated (COKE), Grupo Aeroportuario del Centro Norte S.A.B. de C.V. (OMAB), First Merchants Corporation (FRME), Electronics for Imaging (EFII), West Corporation (WSTC), Independent Bank Corp. (INDB), Barloworld Limited (BRRAY), H.I.S. Co Ltd (HISJF), Children's Place, Inc. (The) (PLCE) and Qualys (QLYS).
How do I buy Pharma Mar stock?
Shares of Pharma Mar can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Pharma Mar's stock price today?
MarketBeat Community Rating for Pharma Mar (NASDAQ PHMMF)MarketBeat's community ratings are surveys of what our community members think about Pharma Mar and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Pharma Mar stock can currently be purchased for approximately $4.05.
Consensus Ratings for Pharma Mar (NASDAQ:PHMMF) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Pharma Mar (NASDAQ:PHMMF)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Pharma Mar (NASDAQ:PHMMF)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Pharma Mar (NASDAQ:PHMMF)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Pharma Mar (NASDAQ:PHMMF)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Pharma Mar (NASDAQ:PHMMF)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Pharma Mar (NASDAQ:PHMMF)
Latest Headlines for Pharma Mar (NASDAQ:PHMMF)
Pharma Mar (PHMMF) Chart for Thursday, September, 21, 2017